STUP-001
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for STUP-001, covering 2025-07-16 to 2025-07-16. Get the full timeline:
Most recent: Clinical Trial Update: First-in-Human Clinical Trial of STUP-001, an In Vivo Direct Cell Conversion Gene Therapy for AIS-A/B Chronic Spinal Cord Injury [Phase 1, Phase 2]